A securities class action has been filed in the USDC – N.J. against Rocket Pharmaceuticals, Inc. (RCKT) (“Rocket” or the “Company”), on behalf of all persons and entities that purchased or otherwise acquired Rocket common stock between February 27, 2025, and May 26, 2025, both dates inclusive (the “Class Period”). Rocket is a fully […]
A securities class action has been filed in the USDC – S.D.N.Y. against Vestis Corporation (VSTS) (“Vestis” or the “Company”), on behalf of all persons and entities that purchased or otherwise acquired Vestis common stock between May 2, 2024, and May 6, 2025, both dates inclusive (the “Class Period”). Vestis is a North American […]
A securities class action has been filed in the USDC – E.D.N.Y. against PepGen Inc. (PEPG) (“PepGen” or the “Company”), on behalf of all persons and entities that purchased or otherwise acquired PepGen securities between March 7, 2024, and March 3, 2025, both dates inclusive (the “Class Period”). PepGen is a clinical-stage biotechnology company […]
A securities class action has been filed in the USDC – S.D.N.Y. against Reckitt Benckiser Group Plc (RBGLY) (“Reckitt” or the “Company”), on behalf of all persons and entities that purchased or otherwise acquired Reckitt American Depositary Shares (“ADSs”) between January 13, 2021, and July 28, 2024, both dates inclusive (the “Class Period”). Reckitt, […]
A securities class action has been filed in the USDC – S.D.FL. against KnowBe4, Inc. (KNBE) (“KnowBe4 ” or the “Company”), on behalf of public holders of KnowBe4 common stock (the “UnaffiliatedStockholders”) as of the December 7, 2022 record date (the “Record Date”) that were entitled to vote on the “take-private” acquisition (the “Merger”) by […]